• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丘脑切开术后帕金森病的质子磁共振波谱变化

Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.

作者信息

Baik Hyun-Man, Choe Bo-Young, Son Byung-Chul, Jeun Sin-Soo, Kim Moon-Chan, Lee Kwang-Soo, Kim Bum-Soo, Lee Jae-Mun, Lee Hyoung-Koo, Suh Tae-Suk

机构信息

Department of Biomedical Engineering, Kangnam St. Mary's Hospital, College of Medicine, Catholic University of Korea, #505 Banpo-Dong, Seocho-Ku, Seoul 137-040, South Korea.

出版信息

Eur J Radiol. 2003 Sep;47(3):179-87. doi: 10.1016/s0720-048x(02)00211-5.

DOI:10.1016/s0720-048x(02)00211-5
PMID:12927660
Abstract

To investigate whether there are significant changes in regional brain metabolism in patients with Parkinson's disease before and after thalamotomy using proton magnetic resonance spectroscopy (1H MRS). Fifteen patients underwent 15 stereotactic thalamotomies for control of medically refractory parkinsonian tremor. Single-voxel 1H MRS was carried out on a 1.5 T unit using stimulated-echo acquisition mode (STEAM) sequence (TR/TM/TE, 2000/14/20 ms). Spectra were obtained from substantia nigra, thalamus and putamen areas with volumes of interests (7-8 ml) in patients before and after the surgery. Metabolite ratios of NAA/Cho, NAA/Cr and Cho/Cr were calculated from relative peak area measurements. We evaluated alterations of metabolite ratios in brain metabolism in Parkinson's disease patients with clinical outcome following thalamotomy. NAA/Cho ratios showed generally low levels in substantia nigra and thalamus in Parkinson's disease patients with clinical improvement following thalamotomy. In 80% (12/15) patients, decreased NAA/Cho ratios were observed from the selected voxels in substantia nigra after thalamic surgery (P<0.05). The ratios were also significantly decreased in thalamus in 67% (10/15) patients with clinical improvement (P<0.05). Our results suggest that NAA/Cho ratio may be a valuable criterion for evaluation of Parkinson's disease patients with the clinical improvement following surgery. 1H MRS may be a useful utility for the aid in better understanding the pathophysiologic process in Parkinson's disease patients on the basis of the variation of NAA/Cho ratio.

摘要

采用质子磁共振波谱(1H MRS)研究帕金森病患者丘脑切开术前、后大脑局部代谢是否存在显著变化。15例患者接受了15次立体定向丘脑切开术以控制药物难治性帕金森震颤。在1.5 T设备上使用刺激回波采集模式(STEAM)序列(TR/TM/TE,2000/14/20 ms)进行单体素1H MRS检查。在手术前后,从黑质、丘脑和壳核区域获取感兴趣体积(7 - 8 ml)的波谱。根据相对峰面积测量计算NAA/Cho、NAA/Cr和Cho/Cr的代谢物比率。我们评估了丘脑切开术后帕金森病患者脑代谢中代谢物比率的变化及其临床结局。丘脑切开术后临床症状改善的帕金森病患者,其黑质和丘脑中NAA/Cho比率总体较低。在80%(12/15)的患者中,丘脑手术后黑质中选定体素的NAA/Cho比率降低(P<0.05)。在67%(10/15)临床症状改善的患者中,丘脑中该比率也显著降低(P<0.05)。我们的结果表明,NAA/Cho比率可能是评估丘脑切开术后临床症状改善的帕金森病患者的一个有价值的指标。基于NAA/Cho比率的变化,1H MRS可能有助于更好地理解帕金森病患者的病理生理过程。

相似文献

1
Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.丘脑切开术后帕金森病的质子磁共振波谱变化
Eur J Radiol. 2003 Sep;47(3):179-87. doi: 10.1016/s0720-048x(02)00211-5.
2
Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.丘脑切开术后帕金森病的代谢改变:1H磁共振波谱分析结果
Korean J Radiol. 2002 Jul-Sep;3(3):180-8. doi: 10.3348/kjr.2002.3.3.180.
3
Detection and application of neurochemical profile by multiple regional H-MRS in Parkinson's disease.通过多区域 H-MRS 检测和应用神经化学谱在帕金森病中的研究。
Brain Behav. 2017 Aug 13;7(9):e00792. doi: 10.1002/brb3.792. eCollection 2017 Sep.
4
Proton MR spectroscopic imaging of the striatum in Parkinson's disease.帕金森病纹状体的质子磁共振波谱成像
Magn Reson Imaging. 1997;15(6):619-24. doi: 10.1016/s0730-725x(97)00079-9.
5
Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study.震颤型帕金森病丘脑神经代谢改变:初步质子磁共振波谱研究。
Parkinsonism Relat Disord. 2017 Oct;43:78-84. doi: 10.1016/j.parkreldis.2017.07.028. Epub 2017 Jul 28.
6
Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy.通过体内1H磁共振波谱分析帕金森病单侧症状的神经元偏侧性
Invest Radiol. 1998 Aug;33(8):450-5. doi: 10.1097/00004424-199808000-00005.
7
Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.质子磁共振波谱在帕金森病黑质代谢物中的应用。
Brain Imaging Behav. 2014 Mar;8(1):97-101. doi: 10.1007/s11682-013-9251-2.
8
Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.未经治疗及左旋多巴治疗的帕金森病患者壳核中N-乙酰天门冬氨酸与胆碱比值的变化:一项质子磁共振波谱研究
Neurology. 1997 Aug;49(2):438-44. doi: 10.1212/wnl.49.2.438.
9
Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.人脑质子磁共振波谱中代谢物峰面积比及水参照代谢物峰面积的序列精度
Magn Reson Imaging. 1998 Apr;16(3):319-30. doi: 10.1016/s0730-725x(97)00280-4.
10
Region-specific Cerebral Metabolic Alterations in Parkinson's Disease Patients With/without Mild Cognitive Impairment.帕金森病患者伴或不伴轻度认知障碍的区域性脑代谢改变。
Neuroscience. 2024 Jul 23;551:254-261. doi: 10.1016/j.neuroscience.2024.05.039. Epub 2024 Jun 6.

引用本文的文献

1
MR Spectroscopy: A Longitudinal Biomarker for Substantia Nigra Pathology in Parkinson's Disease?磁共振波谱:帕金森病黑质病理改变的纵向生物标志物?
Mov Disord. 2015 Sep;30(10):1304-5. doi: 10.1002/mds.26322. Epub 2015 Jul 17.
2
Fast quantification of proton magnetic resonance spectroscopic imaging with artificial neural networks.利用人工神经网络对质子磁共振波谱成像进行快速定量分析。
J Magn Reson. 2006 Nov;183(1):110-22. doi: 10.1016/j.jmr.2006.08.004. Epub 2006 Sep 1.
3
The application of NMR-based metabonomics in neurological disorders.
基于核磁共振的代谢组学在神经系统疾病中的应用。
NeuroRx. 2006 Jul;3(3):358-72. doi: 10.1016/j.nurx.2006.05.004.
4
Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease.定量1H磁共振波谱成像可确定帕金森病动物模型中的治疗性免疫疗效。
J Neurosci. 2005 Feb 16;25(7):1691-700. doi: 10.1523/JNEUROSCI.4364-04.2005.